September 12 2024 - Moderna targets $1.1B in R&D spending cuts, drops 5 programs amid profitability pressures

Moderna targets $1.1B in R&D spending cuts, drops 5 programs amid profitability pressures
Gene therapy startup emerges with green light for first-of-its-kind trial
J&J leads $50M financing for imaging company Spectrawave
GSK's mRNA flu vaccine finally overcomes tricky B strains in phase 2 trial
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*